SSaal-Zapata G., Rodríguez R., Rodriguez-Calienes A., Cordero R. Contralateral catheterization of the ophthalmic artery to deliver intra-arterial chemotherapy in retinoblastoma. The neuroradiology journal. 2021 Jun 13:19714009211024632.
doi: 10.1177/19714009211024632
https://pubmed.ncbi.nlm.nih.gov/34121503/Saal-Zapata G., Rodríguez R., Rodriguez-Calienes A., Cordero R. Contralateral catheterization of the ophthalmic artery to deliver intra-arterial chemotherapy in retinoblastoma. Neuroradiol J. 2021 Aug;34(4):370-372.
doi: 10.1177/19714009211024632
Saengwimol D., Chittavanich P., Laosillapacharoen N., Srimongkol A., Chaitankar V., Rojanaporn D., Aroonroch R., Suktitipat B., Saisawang C., Svasti S., Hongeng S., Kaewkhaw R. Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation. Investigative ophthalmology & visual science. 2020 Dec 1;61(14):8.
doi: 10.1167/iovs.61.14.8
https://pubmed.ncbi.nlm.nih.gov/33270844/Saluja G., Lomi N., Kashyap S. Unilateral retinal dysplasia simulating retinoblastoma. BMJ case reports. 2020 Sep 16;
doi: 10.1136/bcr-2020-238463
https://pubmed.ncbi.nlm.nih.gov/32938657/Salviat F., Gauthier-Villars M., Carton M., Cassoux N., Lumbroso-Le Rouic L., Dehainault C., Levy C., Golmard L., Aerts I., Doz F., Bonnet-Serrano F., Hayek S., Savignoni A., Stoppa-Lyonnet D., Houdayer C. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma. JAMA ophthalmology. 2020 Jun 18
doi: 10.1001/jamaophthalmol.2020.2100
https://pubmed.ncbi.nlm.nih.gov/32556071/Samuel J., Singh N., Kanwar J.R., Krishnakumar S., Kanwar R.K..
Corrigendum to Upregulation of sodium iodide symporter (NIS) protein expression by an innate immunity component: Promising potential for targeting radiosensitive retinoblastoma [Exp. Eye Res. 139 (2015) 108e114]. Experimental eye research. 2020 Aug 11
doi: 10.1016/j.exer.2020.108145
https://pubmed.ncbi.nlm.nih.gov/32797940/Sanati-Mehrizy A., Ghosh T., Peterson E., Starke R.M., Harbour J.W., Corrales-Medina F.F. Hematologic Complications Associated With Intra-arterial Chemotherapy for Retinoblastoma Treatment: A Single Institution Experience. J Pediatr Hematol Oncol. 2022 May 1;44(4):181-185.
doi: 10.1097/MPH.0000000000002451
Santapuram P.R., Schremp E.A., Friedman D.L., Koyama T., Froehler M.T., Daniels A.B. Adverse Events, Burden and Outcomes of IV vs. Intra-arterial Chemotherapy for RB. Ophthalmology Retina. 2020 Sep 10
doi: 10.1016/j.oret.2020.09.006
https://pubmed.ncbi.nlm.nih.gov/32920208/Sari N.M., Hadiputri R., Kuntorini M.S., Agustina H., Mardianty F. High-Risk Histopathologic Features of Retinoblastoma Treated at a Tertiary Hospital in West Java, Indonesia. Ocul Oncol Pathol. 2021 Oct;7(5):353-360.
doi: 10.1159/000517100
Sarver A.L., Xie C., Riddle M.J., Forster C.L., Wang X., Lu H., Wagner W., Tolar J., Hallstrom T.C. Retinoblastoma tumor cell proliferation is negatively associated with an immune gene expression signature and increased immune cells.
Laboratory investigation; a journal of technical methods and pathology. 2021 Mar 3.
doi: 10.1038/s41374-021-00573-x
https://pubmed.ncbi.nlm.nih.gov/33658609/
Schaiquevich P., Francis J.H., Cancela M.B., Carcaboso A.M., Chantada G.L., Abramson D.H. Treatment of Retinoblastoma: What Is the Latest and What Is the Future. Front Oncol. 2022 Apr 1;12:822330. PMID: 35433448; PMCID: PMC9010858. doi: 10.3389/fonc.2022.822330
Schefler A.C., Kim R.S. Recent advancements in the management of retinoblastoma and uveal melanoma. Fac Rev. 2021 May 28;10:51.
doi: 10.12703/r/10-51
Schieffer K.M., Feldman A.Z., Kautto E.A., McGrath S., Miller A.R., Hernandez-Gonzalez M.E., LaHaye S., Miller K.E., Koboldt D.C., Brennan P., Kelly B., Wetzel A., Agarwal V., Shatara M., Conley S., Rodriguez D.P., Abu-Arja R., Shaikhkhalil A., Snuderl M., Orr B.A., Finlay J.L., Osorio D.S., Drapeau A.I., Leonard J.R., Pierson C.R., White P., Magrini V., Mardis E.R., Wilson R.K., Cottrell C.E., Boué D.R..
Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma.
Acta neuropathologica communications. 2021 Apr 7;9(1):61.
doi: 10.1186/s40478-021-01164-z
https://pubmed.ncbi.nlm.nih.gov/33827698/
Schofield D., Zeppel M.J.B, Staffieri S., Shrestha R.N., Jelovic D., Lee E., Jamieson R.V. Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study. Reproductive biomedicine & society online. 2020 May 11.
doi: 10.1016/j.rbms.2020.03.001
https://pubmed.ncbi.nlm.nih.gov/32577540/Schonfeld S.J, Kleinerman R.A., Abramson D.H., Seddon J.M., Tucker M.A., Morton L.M. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.
British journal of cancer. 2021 Jan 21.
doi: 10.1038/s41416-020-01248-y
https://pubmed.ncbi.nlm.nih.gov/33473166/Selvarajah A., Flegg K., Sim W., Hu J.B., Gallie B.L., Shaikh F., Soliman S.E., Dimaras H. Clinical audit of retinoblastoma management: a retrospective single-institution study. Canadian journal of ophthalmology. 2021 May 30:S0008-4182(21)00163-0.
doi: 10.1016/j.jcjo.2021.04.019
https://pubmed.ncbi.nlm.nih.gov/34077747/Selvin S.S.T., Kuriakose T. An uncommon presentation of a refractory case of retinoblastoma. Orbit. 2020 Sep 2
doi: 10.1080/01676830.2020.1817950
https://pubmed.ncbi.nlm.nih.gov/32873110/Sepúlveda-Sánchez J.M., Gil-Gil M., Alonso-García M., Vaz Salgado M.Á., Vicente E., Mesía Barroso C., Rodríguez Sánchez Á., Durán G., De Las Peñas R., Muñoz-Langa J., Velasco G., Hernández-Laín A., Hilario A., Navarro Martín M., Benavides M., Oleaga L., Cantero Montenegro D., Ruano Y., Sánchez-Gómez P., Martín-Soberón M.C., Morales-Llombart R., Pachón V., Pineda E. Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO). Targeted oncology. 2020 Oct;15(5):613-622.
doi: 10.1007/s11523-020-00754-6
https://pubmed.ncbi.nlm.nih.gov/33025213/Sergeenko K.A., Dokuchaeva Y.Y., Kostareva I.O. Aliev T.Z., Elfimova A.Yu., Stepanian N.G., Lozovan Y.V., Burlaka N.A., Sidorova N.V., Machneva E.B., Gorbunova T.V., Ushakova T.L., Polyakov V.G., Kirgizov K.I., Varfolomeeva S.R. High-dose chemotherapy with autologous hemopoietic stem cell transplantation in children with retinoblastoma. Literature review and case series // Cellular Therapy and Transplantation. 2022. Vol. 11. No 1. P. 6-12.
doi: 10.18620/ctt-1866-8836-2022-11-1-6-12
Shah A., Shrestha M., Shrestha S.M., Khatri A., Shrestha P.K. Pathologic Risk Factor in Retinoblastoma: An Institutional Experience Based on Analysis of Enucleated Eyes. Nepal J Ophthalmol. 2021 Jan;13(25):91-97.
doi: 10.3126/nepjoph.v13i1.31139
PMID: 33981102.
Shakeel O., Pace N., Chambers T.M., Scheurer M.E., Ganguly A.A., Lupo P.J., Bunin G.R. Medical radiation exposure and risk of sporadic retinoblastoma.
Pediatric blood & cancer. 2020 Aug 2
doi: 10.1002/pbc.28633
https://pubmed.ncbi.nlm.nih.gov/32743912/Shanmugam P.M. Commentary: Retinoblastoma management-Where are we and where do we go from here? Indian journal of ophthalmology. 2020 Nov;68(11):2365-2366.
doi: 10.4103/ijo.IJO_1954_20
https://pubmed.ncbi.nlm.nih.gov/33120618/Shanthini T., Balaji S., Kim U., Muthukkaruppan V., Vanniarajan A. Genetic characterization of a patient with an unusual presentation of Waardenburg syndrome Type 4 and retinoblastoma. Pediatric blood & cancer. 2020 Jul 16
doi: 10.1002/pbc.28553
https://pubmed.ncbi.nlm.nih.gov/32672397/
Shapira Y., Worrell E., Litwin A.S., Malhotra R. The UK National Artificial Eye Questionnaire Study: predictors of artificial eye wearers' experience Part 2: visual function and quality of life. Eye (Lond). 2022 Jan;36(1):140-147. Epub 2021 Mar 1.
doi: 10.1038/s41433-021-01459-4
Shapira Y., Worrell E., Ullrich K., Litwin A., Malhotra R. UK National Artificial Eye Questionnaire study: comparisons between cosmetic shell and artificial eye users. Part 1: demographics, comfort and satisfaction. Br J Ophthalmol. 2021 Oct;105(10):1346-1351.
doi: 10.1136/bjophthalmol-2020-317015
Sheehan A.P. Retinoblastoma: Early Diagnosis is Crucial. Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners. 2020 Aug 24
doi: 10.1016/j.pedhc.2020.06.006
https://pubmed.ncbi.nlm.nih.gov/32855014/
Sheng J., Kohno S., Okada N., Okahashi N., Teranishi K., Matsuda F., Shimizu H., Linn P., Nagatani N., Yamamura M., Harada K., Horike SI., Inoue H., Yano S., Kumar S., Kitajima S., Ajioka I., Takahashi C. Treatment of Retinoblastoma 1-Intact Hepatocellular Carcinoma With Cyclin-Dependent Kinase 4/6 Inhibitor Combination Therapy. Hepatology. 2021 Oct;74(4):1971-1993.
doi: 10.1002/hep.31872
Shields C.L., Bas Z., Laiton A., Silva A.M.V., Sheikh A., Lally S.E., Shields J.A. Retinoblastoma: emerging concepts in genetics, global disease burden, chemotherapy outcomes, and psychological impact. Eye (Lond). 2022 Feb 25:1–8. Epub ahead of print.
doi: 10.1038/s41433-022-01980-0
Shields C.L., Bas Z., Tadepalli S., Dalvin L.A., Rao R., Schwendeman R., Lally S.E., Shields J.A., Shah A., Leahey A. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre. Br J Ophthalmol. 2020 Feb 12.
DOI: 10.1136/bjophthalmol-2019-315572
Singh N., DeBenedictis M.J., Singh A.D. An Online Application for Retinoblastoma Surveillance. Ocular oncology and pathology. 2020 Oct; 6.
doi: 10.1159/000505751
https://pubmed.ncbi.nlm.nih.gov/33123532/
Shields C.L., Dockery P.W., Yaghy A., Duffner E.R., Levin H.J., Taylor O.S., Sajjadi Z., Lally S.E., Shields J.A., Rosenwasser R., Tjoumakaris S., Jabbour P. Intra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1,292 infusions): comparative analysis of outcomes based on patient age, race, and sex. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, S1091-8531(21)00112-9. 24 May. 2021. doi:10.1016/j.jaapos.2020.12.006
https://pubmed.ncbi.nlm.nih.gov/34044113/
Shields C.L., Dockery P., Ruben M., Yaghy A., Sunday M.A., Duffner E.R., Levin H.J., Taylor O.S., Calotti M., Lally S.E., Shields J.A. Likelihood of Germline Mutation With Solitary Unilateral Retinoblastoma Based on Patient Age at Presentation: Analysis of 482 Consecutive Patients. Journal of pediatric ophthalmology and strabismus. 2021 Jun 1:1-10.
doi: 10.3928/01913913-20210414-02
https://pubmed.ncbi.nlm.nih.gov/34180289/
Shields C.L., Srinivasan A., Lucio-Alvarez J.A., Shields J.A. Retinocytoma/retinoma: comparative analysis of clinical features in 78 tumors and rate of transformation into retinoblastoma over 20 years. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2021 May 26:S1091-8531(21)00132-4.
doi: 10.1016/j.jaapos.2020.11.024
https://pubmed.ncbi.nlm.nih.gov/34051357/
Shi J., Sun J., Liu L., Shan T., Meng H., Yang T., Wang S., Wei T., Chen B., Ma Y., Wang Q., Wang H., Liu J., Wang L. P16ink4a overexpression ameliorates cardiac remodeling of mouse following myocardial infarction via CDK4/pRb pathway. Biochem Biophys Res Commun. 2022 Jan 22;595:62-68. Epub ahead of print.
doi: 10.1016/j.bbrc.2022.01.077
Shi K., Zhu X., Wu J., Chen Y., Zhang J., Sun X. Centromere protein E as a novel biomarker and potential therapeutic target for retinoblastoma. Bioengineered. 2021 Dec;12(1):5950-5970.
doi: 10.1080/21655979.2021.1972080
Silva-Teixeira R., Laranjo M., Lopes B., Almeida-Ferreira C., Gonçalves A.C., Rodrigues T., Matafome P., Sarmento-Ribeiro A.B., Caramelo F., Botelho M.F. Plasma activated media and direct exposition can selectively ablate retinoblastoma cells. Free radical biology & medicine. 2021 May 20;171:302-313.
doi: 10.1016/j.freeradbiomed.2021.05.027
https://pubmed.ncbi.nlm.nih.gov/34022401/
Silva-Teixeira R., Laranjo M., Lopes B., Almeida-Ferreira C., Gonçalves A.C., Rodrigues T., Matafome P., Sarmento-Ribeiro A.B., Caramelo F., Botelho M.F. Plasma activated media and direct exposition can selectively ablate retinoblastoma cells. Free Radic Biol Med. 2021 Aug 1;171:302-313.
doi: 10.1016/j.freeradbiomed.2021.05.027
Silvera V.M., Guerin J.B., Brinjikji W., Dalvin L.A. Retinoblastoma: What the Neuroradiologist Needs to Know. AJNR. American journal of neuroradiology. 2021 Jan 28.
doi: 10.3174/ajnr.A6949
https://pubmed.ncbi.nlm.nih.gov/33509920/Singh L., Singh M.K., Rizvi M.A., Bakhshi S., Meel R., Lomi N., Sen S., Kashyap S. Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma.
DOI: 10.1007/s00262-020-02529-4
Skalet A.H., Allen R.C., Shields C.L., Wilson M.W., Mruthyunjaya P., Gombos D.S. Considerations for the Management and Triage of Ocular Oncology Cases during the COVID-19 Pandemic. Ocular oncology and pathology. 2020 Apr 21.
DOI:
10.1159/000507734https://pubmed.ncbi.nlm.nih.gov/32411697/?from_term=retinoblastoma&from_sort=date&from_page=3&from_pos=6Skalet A.H., Campbell J.P., Jian Y. Ultrawide-field OCT for Retinoblastoma. Ophthalmology. 2022 Jun;129(6):718. PMID: 35598905.
doi: 10.1016/j.ophtha.2021.11.012
Skilton A.M., Low L.G., Dimaras H. Patients, Public and Service Users are Experts by Experience: An Overview from Ophthalmology Research in Canada, UK and Beyond. Ophthalmol Ther. 2020 Feb 29.
DOI: 10.1007/s40123-020-00237-x
https://link.springer.com/arti…/10.1007%2Fs40123-020-00237-x
Solana-Altabella A., Valero S., Balaguer J., Escobar-Cava P., Barranco H., López E., Ribes-Artero H., Poveda J.L. Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol. J Oncol Pharm Pract. 2020 Feb 17:1078155220904410.
DOI: 10.1177/1078155220904410
Soliman S.E., Martínez S., De Nicola M.L., Kiehl R., Krema H. Molecular analysis confirms retinoblastoma diagnosis in a histologically undifferentiated retinal tumor in an adult. Ophthalmic genetics. 2020 Jun 16.
doi: 10.1080/13816810.2020.1765398
https://pubmed.ncbi.nlm.nih.gov/32543965/Soliman S.E., Bansal A., De Nicola M.L., Bhambhwani V., Laperriere N., Gallie B.L., Krema H. Applications of iodine-125 plaque radiotherapy for residual or recurrent retinoblastoma. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2021 Jan 23:S0008-4182(21)00001-6.
doi: 10.1016/j.jcjo.2020.12.016
https://pubmed.ncbi.nlm.nih.gov/33493457/
Soliman S.E., Bansal A., De Nicola M.L., Bhambhwani V., Laperriere N., Gallie B.L., Krema H. Applications of iodine-125 plaque radiotherapy for residual or recurrent retinoblastoma. Can J Ophthalmol. 2021 Oct;56(5):317-324.
doi: 10.1016/j.jcjo.2020
Soliman S.E., Vanden Hoven C., MacKeen L.D., Gallie B.L. Secondary Prevention of Retinoblastoma Revisited: Laser Photocoagulation of Invisible New Retinoblastoma. Ophthalmology. 2020 Jan;127(1):122-127.
DOI: 10.1016/j.ophtha.2019.08.011
https://www.aaojournal.org/a…/S0161-6420(19)31933-5/fulltextSoliman S., Feng Z.X., Gallie B. Primary laser therapy as monotherapy for discrete retinoblastoma. The British journal of ophthalmology. 2021 Feb 3:bjophthalmol-2020-317885.
doi: 10.1136/bjophthalmol-2020-317885
https://pubmed.ncbi.nlm.nih.gov/33536230/
Soltani S., Tabibzadeh A., Yousefi P., Zandi M., Zakeri A., Akhavan Rezayat S., Ramezani A., Esghaei M., Farahani A. HPV infections in retinoblastoma: a systematic review. J Clin Lab Anal. 2021 Aug 30:e23981.
doi: 10.1002/jcla.23981
https://onlinelibrary.wiley.com/doi/10.1002/jcla.23981 Song J., Zhang Z. Long non‑coding RNA SNHG20 promotes cell proliferation, migration and invasion in retinoblastoma via the miR‑335‑5p/E2F3 axis. Mol Med Rep. 2021 Aug;24(2):543.
doi: 10.3892/mmr.2021.12182
Song K., Li B., Chen Y.Y., Wang H., Liu K.C., Tan W., Zou J. LRPPRC regulates metastasis and glycolysis by modulating autophagy and the ROS/HIF1-α pathway in retinoblastoma. Mol Ther Oncolytics. 2021 Jun 24;22:582-591.
doi: 10.1016/j.omto.2021.06.009
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450181/ Song L., Huang Y., Zhang X., Han S., Hou M., Li H. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2. Investigative Ophthalmology & Visual Science.. 2020 Mar 9
DOI: 10.1167/iovs.61.3.32
https://pubmed.ncbi.nlm.nih.gov/32186675/?from_term=retinoblastoma&from_sort=pubdate&from_size=50&from_pos=49
Song L., Wang Y., Cui J., Zhang W., Zhang D., Wang X., Wang Z., Zhao Y., Zhang C., Duan C., Sun T., Zhang L., Yang X. Characteristics of Myelogram in Patients with Extraocular Metastatic Retinoblastoma and Morphological Analysis of Tumor Cells in Bone Marrow and Cerebrospinal Fluid.
Ophthalmologica. 2020 Oct 12.
doi: 10.1159/000512193
https://pubmed.ncbi.nlm.nih.gov/33045702/Song W.P., Zheng S., Yao H.J., Zhou X.F., Li R., Zhang C.Y., Zhao J.Y., Wang L.W., Shao R.G., Li L. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism. // BMC Ophthalmology. 2020 Mar 6.
DOI: 10.1186/s12886-020-01348-6
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060629/Sradhanjali S., Rout P., Tripathy D., Kaliki S., Rath S., Modak R., Mittal R., Chowdary T.K., Reddy M.M.. The Oncogene
MYCN Modulates Glycolytic and Invasive Genes to Enhance Cell Viability and Migration in Human Retinoblastoma. Cancers (Basel). 2021 Oct 19;13(20):5248.
doi: 10.3390/cancers13205248
PMID: 34680394; PMCID: PMC8533785.
Stacey A.W., Bowman R., Foster A., Kivelä T.T., Munier F.L., Cassoux N., Fabian I.D.; Global Retinoblastoma Study Group, Al Harby L., Alarcón Portabella S., Alia D.B., All-Eriksson C., Antonino R., Astbury N.J., Balaguer J., Balwierz W., Barranco H., Bascaran C., Beck Popovic M., Biewald E.M., Bobrova N., Bornfeld N., Brichard B.G., Blum S., Capra M., Castela G., Català-Mora J., Chantada G.L., Chernodrinska V.S., Cieslik K., Comsa C., Correa Llano M.G., Csóka M., De Potter P., Desjardins L., Dragomir M.D., Fernández-Teijeiro A., García Aldana D., Gregersen P.A., Gomel N., Hadjistilianou T., Hederova S., Hummlen M., Husakova K., Ida R., Ilic V.R., Jenkinson H., Kapelushnik N., Kardava T., Keren-Froim N., Kepak T., Khotenashvili Z., Klett A., Krivaitiene D., Latinović S., Lumbroso L., Lysytsia L., Maka E., Martín Begue N., Midena E., Moll A.C., Murgoi G., Naumenko L., Neroev V., Nikitovic M., Olechowski A., Papyan R., Parrozzani R., Parulekar M.V., Pawinska-Wasikowska K., Perić S., Pochop P., Polyakov V.G., Reddy M.A., Ritter-Sovinz P., Saakyan S., Sagoo M.S., San Román Pacheco S., Seregard S., Silva S., Sorochynska T., Stathopoulos C., Stirn Kranjc B., Svojgr K., Tamamyan G., Tandili A., Tateshi B., Tekavcic Pompe M., Urbak S.F., Ushakova T.L., Valeina S., van Hoefen Wijsard M., Veleva-Krasteva N.V., Viksnins M., Wackernagel W., Wolley Dod C., Yarovaya V.A., Yarovoy A.A., Zhilyaeva K., Zondervan M.
Incidence of retinoblastoma has increased: results from 40 European countries.
Ophthalmology. 2021 Jan 25:S0161-6420(21)00072-5.
doi: 10.1016/j.ophtha.2021.01.024
https://pubmed.ncbi.nlm.nih.gov/33508429/
Stacey A.W., Bowman R., Foster A., Kivelä T.T., Munier F.L., Cassoux N., Fabian I.D.; Global Retinoblastoma Study Group. Incidence of Retinoblastoma Has Increased: Results from 40 European Countries. Ophthalmology. 2021 Sep;128(9):1369-1371.
doi: 10.1016/j.ophtha.2021.01.024
Stacey A.W., De Francesco S., Borri M., Hadjistilianou T. The addition of topotecan to melphalan in the treatment of retinoblastoma with intra-arterial chemotherapy. Ophthalmology. Retina. 2020 Nov 19:S2468-6530(20)30459-0.
doi: 10.1016/j.oret.2020.11.007
https://pubmed.ncbi.nlm.nih.gov/33221516/Stacey A.W., De Francesco S., Borri M., Hadjistilianou T. The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy. Ophthalmol Retina. 2021 Aug; 5(8):824-830.
doi: 10.1016/j.oret.2020.11.007
https://www.sciencedirect.com/science/article/abs/pii/S2468653020304590?via%3Dihub
Stacey A.W., Tsukikawa M., Fabian I.D., Turner S., Jenkinson H., Smith V., Naeem Z., Morland B., Ainsworth J.R., Reddy M.A., Parulekar M., Sagoo M.S. Adjuvant use of laser in eyes with macular retinoblastoma treated with primary intravenous chemotherapy. The British journal of ophthalmology. 2020 Sep 15
doi: 10.1136/bjophthalmol-2020-316862
https://pubmed.ncbi.nlm.nih.gov/32933939/ Stacey A.W., Tsukikawa M., Fabian I.D., Turner S., Jenkinson H., Smith V., Naeem Z., Morland B., Ainsworth J.R., Reddy M.A., Parulekar M., Sagoo M.S. Adjuvant use of laser in eyes with macular retinoblastoma treated with primary intravenous chemotherapy. Br J Ophthalmol. 2021 Nov;105(11):1599-1603.
doi: 10.1136/bjophthalmol-2020-316862
Stathopoulos C., Bartolini B., Marie G., Beck-Popovic M., Saliou G., Munier F.L. Risk factors for acute choroidal ischemia after intra-arterial melphalan for retinoblastoma: the role of the catheterization approach. Ophthalmology. 2020 Sep 18
doi: 10.1016/j.ophtha.2020.09.021
https://pubmed.ncbi.nlm.nih.gov/32956742/
Stathopoulos C., Lumbroso-Le Rouic L., Moll A.C., Parulekar M., Maeder P., Doz F., Jenkinson H., Beck Popovic M., Chantada G., Munier F.L. Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG). Cancers (Basel). 2021 Jul 6;13(14):3392.
PMID: 34298608; PMCID: PMC8303810.
https://doi.org/10.3390/cancers13143392Stathopoulos C., Sergenti J., Gaillard M.C., Munier F.L., Daruich A. Pars plana vitrectomy under melphalan irrigation for recurrent retinal detachment in eyes treated for retinoblastoma: a case report. BMC Ophthalmol. 2020 Jan 28;20(1):34.
DOI: 10.1186/s12886-020-1315-7
Strijbis V.I.J., de Bloeme C.M., Jansen R.W., Kebiri H., Nguyen H.G., de Jong M.C., Moll A.C., Bach-Cuadra M., de Graaf P., Steenwijk M.D. Multi-view convolutional neural networks for automated ocular structure and tumor segmentation in retinoblastoma. Sci Rep. 2021 Jul 16;11(1):14590.
doi: 10.1038/s41598-021-93905-2
Stuart K.V., Shepherd D.J., Kruger M., Singh E. The Incidence of Retinoblastoma in South Africa: Findings from the South African National Cancer Registry (2004-2018). Ophthalmic Epidemiol. 2021 Dec 22:1-7.
doi: 10.1080/09286586.2021.2013900
Sujjitjoon J., Sayour E., Tsao S.T., Uiprasertkul M., Sanpakit K., Buaboonnam J., Yenchitsomanus P.T., Atchaneeyasakul L.O., Chang L.J. GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma - assessing tumor and T cell interaction. Translational oncology. 2020 Dec 12;14(2):100971.
doi: 10.1016/j.tranon.2020.100971
https://pubmed.ncbi.nlm.nih.gov/33321428/Suleiman D.E., Iliyasu Y., Ahmed S.A., Liman A.A. Histopathologic spectrum of paediatric eye and ocular adnexal tumours: A 10-year review from a referral centre in Nigeria. Nigerian journal of clinical practice. 2020 May;23
DOI:
10.4103/njcp.njcp_389_19https://pubmed.ncbi.nlm.nih.gov/32367872/?from_term=retinoblastoma&from_sort=date&from_page=5&from_pos=5Sun J., Feng D., Xi H., Luo J., Zhou Z., Liu Q., Chen Y., Shao Q. CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy. Molecular oncology. 2020 May 12.
DOI:
10.1002/1878-0261.12708https://pubmed.ncbi.nlm.nih.gov/32394616/?from_term=retinoblastoma&from_sort=date&from_page=4&from_pos=5Sun J., Xi H.Y., Shao Q., Liu Q.H. Biomarkers in retinoblastoma Int J Ophthalmol. 2020 Feb 18;13(2):325-341.
DOI: 10.18240/ijo.2020.02.18. eCollection 2020.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013786/Sun S., Wang R., Yi S., Li S., Wang L., Wang J. Roles of the microRNA‑338‑3p/NOVA1 axis in retinoblastoma. Molecular medicine reports. 2021 May;23(5):394.
doi: 10.3892/mmr.2021.12033
https://pubmed.ncbi.nlm.nih.gov/33760207/Sun X., Shen H., Liu S., Gao J., Zhang S. Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA‑124 and thereby upregulating STAT3.International Journal of Molecular Medicine. 2020 Mar 20
DOI: 10.3892/ijmm.2020.4547
https://pubmed.ncbi.nlm.nih.gov/32236565/?from_term=retinoblastoma&from_sort=date&from_page=3&from_pos=5Sun Z., Zhang A., Hou M., Jiang T. Circular RNA hsa_circ_0000034 promotes the progression of retinoblastoma via sponging microRNA-361-3p. Bioengineered. 2020 Dec;11(1):949-957.
doi: 10.1080/21655979.2020.1814670
https://pubmed.ncbi.nlm.nih.gov/32892696/Sweid A., El Naamani K., Sajja K.C., Hammoud B., Knapp M.D., Moylan D.D., Joffe D., Morse C.E., Habbal D., Weinberg J.H., Tjoumakaris S.I., Shields C.L., Lezama D.A., Lim L.S., Dalvin L.A., Rosenwasser R., Jabbour P. Incidence and predictors of ophthalmic artery occlusion in intra-arterial chemotherapy for retinoblastoma. Journal of neurointerventional surgery. 2020 Oct 29
doi: 10.1136/neurintsurg-2020-016759
https://pubmed.ncbi.nlm.nih.gov/33122349/Sweid A., Hammoud B., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Tjoumakaris S., Shields C.L., Ancona-Lezama D., Lim L.S., Dalvin L.A., Maamari D.J., Jabbour P. The Use of Alternative Routes for the Delivery of Intra-Arterial Chemotherapy for Retinoblastoma.
Neurosurgery online. 2020 May 12.
DOI:
10.1093/neuros/nyaa142https://pubmed.ncbi.nlm.nih.gov/32396190/?from_term=retinoblastoma&from_sort=date&from_page=4&from_pos=4Sweid A., Hammoud B., Weinberg J.H., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Ramesh S., Tjoumakaris S., Shields C.L., Ancona-Lezama D., Lim L.S., Dalvin L.A., Jabbour P. Intra-Arterial Chemotherapy for Retinoblastoma in Infants ≤10 Kg: 74 Treated Eyes With 222 IAC Sessions. American journal of neuroradiology. 2020 June 25.
doi: 10.3174/ajnr.A6590
https://pubmed.ncbi.nlm.nih.gov/32586963/
Sweid A., Hammoud B., Weinberg J.H., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Tjoumakaris S.I., Shields C.L., Lezama D.A., Lim L.S., Dalvin L.A., El Naamani K., Jabbour P. Ophthalmic artery catheterization for retinoblastoma treatment: does reflux affect tumor response? Journal of NeuroInterventional Surgery. 2020 Apr 9
DOI: 10.1136/neurintsurg-2019-015597
https://pubmed.ncbi.nlm.nih.gov/32277036/?from_term=retinoblastoma&from_sort=date&from_pos=7
Sweid A., Jabbour P. Intra-arterial chemotherapy for retinoblastoma: transradial and transfemoral approach. Journal of neurointerventional surgery. 2020 May 15/
DOI:
10.1136/neurintsurg-2019-015627https://pubmed.ncbi.nlm.nih.gov/32414893/?from_term=retinoblastoma&from_sort=date&from_page=3&from_pos=4